Our results suggest that genes that are directly (NFKB, IL12A, IL21, and C-REL) or indirectly (SH2B3 and RGS1) involved in inflammation or damage processes are significantly up-regulated in CeD patients, in at least one cellular compartment. This evidence concerns the gene REL and cranioectodermal dysplasia.